Literature DB >> 2161707

Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice.

Y Matsui1, S A Halter, J T Holt, B L Hogan, R J Coffey.   

Abstract

To study the role of transforming growth factor alpha (TGF alpha) in normal mammary development and mammary neoplasia in vivo, we have generated transgenic mice in which a human TGF alpha cDNA is expressed under the control of the MMTV enhancer/promoter. Overexpression of TGF alpha in the mammary epithelium, as confirmed by in situ hybridization and immunohistochemistry, is associated with hyperplasia of alveoli and terminal ducts in virgin female and pregnant transgenic mice. A range of morphologic abnormalities including lobular hyperplasia, cystic hyperplasia, adenoma, and adenocarcinoma is seen in mammary tissue of transgenic females. In contrast, no morphologic abnormalities are seen in transgenic males in spite of TGF alpha overexpression in salivary glands and reproductive organs. TGF alpha can therefore act as an oncogene in vivo and appears to predispose mammary epithelium to neoplasia and carcinoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161707     DOI: 10.1016/0092-8674(90)90077-r

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  112 in total

Review 1.  Role of mesenchymal-epithelial interactions in mammary gland development.

Authors:  G R Cunha; Y K Hom
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-01       Impact factor: 2.673

2.  Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice.

Authors:  A E Lenferink; J F Simpson; L K Shawver; R J Coffey; J T Forbes; C L Arteaga
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

3.  Efficient and specific ribozyme-mediated reduction of bovine alpha-lactalbumin expression in double transgenic mice.

Authors:  P J L'Huillier; S Soulier; M G Stinnakre; L Lepourry; S R Davis; J C Mercier; J L Vilotte
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-25       Impact factor: 11.205

4.  Estradiol-dependent uterine leiomyomas in transgenic mice.

Authors:  B Romagnolo; T Molina; G Leroy; C Blin; A Porteux; M Thomasset; A Vandewalle; A Kahn; C Perret
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

5.  Biological indices in the assessment of breast cancer.

Authors:  A S Leong; A K Lee
Journal:  Clin Mol Pathol       Date:  1995-10

6.  Altered EGFR localization and degradation in human breast cancer cells with an amphiregulin/EGFR autocrine loop.

Authors:  Nicole E Willmarth; Andrea Baillo; Michele L Dziubinski; Kristy Wilson; David J Riese; Stephen P Ethier
Journal:  Cell Signal       Date:  2008-10-14       Impact factor: 4.315

7.  Elevated plasma transforming growth factor-beta 1 levels in breast cancer patients decrease after surgical removal of the tumor.

Authors:  F M Kong; M S Anscher; T Murase; B D Abbott; J D Iglehart; R L Jirtle
Journal:  Ann Surg       Date:  1995-08       Impact factor: 12.969

8.  A role for KAI1 in promotion of cell proliferation and mammary gland hyperplasia by the gp78 ubiquitin ligase.

Authors:  Bharat Joshi; Lei Li; Ivan R Nabi
Journal:  J Biol Chem       Date:  2010-01-20       Impact factor: 5.157

9.  Mammary tumor suppression by transforming growth factor beta 1 transgene expression.

Authors:  D F Pierce; A E Gorska; A Chytil; K S Meise; D L Page; R J Coffey; H L Moses
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice.

Authors:  W J Muller; C L Arteaga; S K Muthuswamy; P M Siegel; M A Webster; R D Cardiff; K S Meise; F Li; S A Halter; R J Coffey
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.